2023 | BioSenic

BioSenic appoints Lieven Huysse, MD, as Chief Medical Officer

Read more about BioSenic appoints Lieven Huysse, MD, as Chief Medical Officer

BioSenic publie une mise à jour financière et présente le calendrier financier 2023

Read more about BioSenic publie une mise à jour financière et présente le calendrier financier 2023

BioSenic provides Financial Update and Financial Calendar 2023

Read more about BioSenic provides Financial Update and Financial Calendar 2023

BioSenic publishes new data on the mechanism of action of arsenic trioxide (ATO)

Read more about BioSenic publishes new data on the mechanism of action of arsenic trioxide (ATO)

BioSenic publie de nouvelles données sur le mécanisme d'action du trioxyde d'arsenic (ATO)

Read more about BioSenic publie de nouvelles données sur le mécanisme d'action du trioxyde d'arsenic (ATO)

JTA nouvelle analyse post-hoc de son essai phase III

Read more about JTA nouvelle analyse post-hoc de son essai phase III

JTA new post-hoc analysis of its phase III trial

Read more about JTA new post-hoc analysis of its phase III trial

Information on the total number of voting rights and shares

Read more about Information on the total number of voting rights and shares

ALLOB Subscription Rights

Read more about ALLOB Subscription Rights

ALLOB optimization statistical analysis and complete patient recruitment

Read more about ALLOB optimization statistical analysis and complete patient recruitment

Subscribe to 2023